For patients with prostate cancer, a natural compound, alternol, plays a specific-cancer curing role by curbing the activity of four Krebs cycle enzymes, including DLAT, contributing to the reduction of mitochondrial respiration and excessive adenosine triphosphate production in cancer cells and xenografts (Li et al., 2019). Here, DLAT is linked to cancer.